Prokidney Corp.
PROK- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850270
In the last 90 days, Prokidney Corp. insiders filed 0 open-market purchases and 1 sale; 71 institutions reported holding it in 13F filings for Q2 2026, worth $99.5M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Prokidney Corp. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 35 | 56 | +21 |
| Shares | 34.6M | 39.8M | +5.25M (+15.2%) |
| Value | $391.2M | $445.6M | +$54.4M (+13.9%) |
New holders (27)
Institutions that held Prokidney Corp. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (6)
Institutions that held Prokidney Corp. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Millennium Management LLC | 102,059 | $1.16M |
| HRT Financial LP | 64,507 | $730.0K |
| UBS Oconnor LLC | 49,782 | $563.5K |
| Squarepoint Ops LLC | 25,883 | $293.0K |
| ExodusPoint Capital Management, LP | 13,343 | $151.0K |
| Tudor Investment Corp Et Al | 12,917 | $146.0K |